Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Reports outline life sciences research from University of Pisa
March 18th, 2009
New research, 'Phagocytosis, germination and killing of Bacillus subtilis spores presenting heterologous antigens in human macrophages,' is the subject of a report. According to a study from Pisa, Italy, "Bacillus subtilis is a Gram-positive spore-bearing bacterium long used as a probiotic product and more recently regarded as an attractive vehicle for delivering heterologous antigens to be used for mucosal vaccination. This report describes the in vitro interaction between human macrophages and B. subtilis spores displaying the tetanus toxin fragment C or the B subunit of the heat-labile toxin of Escherichia coli on their surface in comparison to spores of the parental...
Source: Vaccine Weekly (2009-03-18)
|
